A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
1 other identifier
interventional
1,711
1 country
142
Brief Summary
This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and the target sample size is 1776 individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jun 2004
142 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 6, 2015
CompletedFirst Posted
Study publicly available on registry
November 13, 2015
CompletedNovember 2, 2016
November 1, 2016
1.8 years
November 6, 2015
November 1, 2016
Conditions
Outcome Measures
Primary Outcomes (3)
Part A: Number of participants who currently use weekly biphosphonate who answer "yes" to any of the questions in Candidate Identification Questionnaire (CIQ)
Up to 30 days prior to baseline visit
Part B: Number of participants who demonstrate improvement from their baseline satisfaction score after 6 months of ibandronate
6 months
Part B: Percentage of participants who demonstrate improvement from their baseline satisfaction score after 6 months of ibandronate
6 months
Secondary Outcomes (13)
Part B: Percentage of eligible weekly biphosphonate users at screening who elect to enter Part B
Screening visit
Part B: Percentage of participants who report an improved satisfaction score with monthly ibandronate compared to weekly alendronate or risendronate
6 months
Part B: Percentage of participants who report preference to monthly ibandronate or weekly alendronate or risedronate
6 months
Part B: Percentage of participants who have greater than or equal to (>=) 80 percent (%) compliance
6 months
Part B: Percentage of participants who report an improvement in the gastrointestinal (GI) symptoms
6 months
- +8 more secondary outcomes
Study Arms (1)
Ibandronate
EXPERIMENTALParticipants will receive 150 milligrams (mg) of ibandronate as a film-coated tablet once-monthly.
Interventions
Film-coated oral ibandronate tablet (150 mg) once-monthly
Eligibility Criteria
You may qualify if:
- \- Women who had been receiving once-weekly alendronate or risedronate for treatment or prevention of post-menopausal osteoporosis for greater than or equal to (\>=) 3 months
You may not qualify if:
- Inability to stand or sit upright for \>=60 minutes
- Hypersensitivity to bisphosphonates
- Inability to swallow a tablet whole
- Malignant disease diagnosed within previous 10 years (except resected basal cell cancer).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (142)
Unknown Facility
Birmingham, Alabama, 35235, United States
Unknown Facility
Columbiana, Alabama, 35051, United States
Unknown Facility
Huntsville, Alabama, 35801, United States
Unknown Facility
Mobile, Alabama, 36608, United States
Unknown Facility
Montgomery, Alabama, 36111, United States
Unknown Facility
Chandler, Arizona, 85225, United States
Unknown Facility
Gilbert, Arizona, 85295, United States
Unknown Facility
Paradise Valley, Arizona, 85253, United States
Unknown Facility
Phoenix, Arizona, 85006, United States
Unknown Facility
Phoenix, Arizona, 85014, United States
Unknown Facility
Tempe, Arizona, 85282, United States
Unknown Facility
Tucson, Arizona, 85712, United States
Unknown Facility
Carlisle, Arkansas, 72024, United States
Unknown Facility
Jonesboro, Arkansas, 72401, United States
Unknown Facility
Little Rock, Arkansas, 72205, United States
Unknown Facility
Pine Bluff, Arkansas, 71603, United States
Unknown Facility
Rogers, Arkansas, 72756, United States
Unknown Facility
Searcy, Arkansas, 72143, United States
Unknown Facility
Sherwood, Arkansas, 72120, United States
Unknown Facility
Anaheim, California, 92801, United States
Unknown Facility
Beverly Hills, California, 90211, United States
Unknown Facility
Laguna Hills, California, 92653, United States
Unknown Facility
Mission Viejo, California, 92691, United States
Unknown Facility
Palm Desert, California, 92260, United States
Unknown Facility
Palo Alto, California, 94304, United States
Unknown Facility
Sacramento, California, 95825, United States
Unknown Facility
San Diego, California, 92128, United States
Unknown Facility
Tacoma, California, 98405, United States
Unknown Facility
Vista, California, 92083, United States
Unknown Facility
Westlake Village, California, 91361, United States
Unknown Facility
Colorado Springs, Colorado, 80909, United States
Unknown Facility
Lakewood, Colorado, 80260, United States
Unknown Facility
Avon, Connecticut, 06001, United States
Unknown Facility
Cromwell, Connecticut, 06416, United States
Unknown Facility
Hamden, Connecticut, 06518, United States
Unknown Facility
New London, Connecticut, 06320, United States
Unknown Facility
Waterbury, Connecticut, 06708, United States
Unknown Facility
Wilmington, Delaware, 19805, United States
Unknown Facility
Aventura, Florida, 33180, United States
Unknown Facility
Clearwater, Florida, 33761, United States
Unknown Facility
DeLand, Florida, 32720, United States
Unknown Facility
Fort Myers, Florida, 33916, United States
Unknown Facility
Gainesville, Florida, 32605, United States
Unknown Facility
Gainesville, Florida, 32607, United States
Unknown Facility
Longwood, Florida, 32779, United States
Unknown Facility
Melbourne, Florida, 32901, United States
Unknown Facility
Miami, Florida, 33186, United States
Unknown Facility
Ocala, Florida, 34471, United States
Unknown Facility
Palm Bay, Florida, 32905, United States
Unknown Facility
Palm Harbor, Florida, 34684, United States
Unknown Facility
Port Orange, Florida, 32127, United States
Unknown Facility
Sarasota, Florida, 34239, United States
Unknown Facility
West Palm Beach, Florida, 33409, United States
Unknown Facility
Atlanta, Georgia, 30309, United States
Unknown Facility
Augusta, Georgia, 30904, United States
Unknown Facility
Decatur, Georgia, 30033, United States
Unknown Facility
Rome, Georgia, 30165, United States
Unknown Facility
Boise, Idaho, 83712, United States
Unknown Facility
Coeur d'Alene, Idaho, 83814, United States
Unknown Facility
Champaign, Illinois, 61820, United States
Unknown Facility
Creve Coeur, Illinois, 61610, United States
Unknown Facility
Peoria, Illinois, 61615, United States
Unknown Facility
Evansville, Indiana, 47714, United States
Unknown Facility
Arkansas City, Kansas, 67005, United States
Unknown Facility
Newton, Kansas, 67114, United States
Unknown Facility
Wichita, Kansas, 67207, United States
Unknown Facility
Natchitoches, Louisiana, 71457, United States
Unknown Facility
New Orleans, Louisiana, 70119, United States
Unknown Facility
Baltimore, Maryland, 21204, United States
Unknown Facility
Bethesda, Maryland, 20817, United States
Unknown Facility
Chelsea, Michigan, 48118, United States
Unknown Facility
Detroit, Michigan, 48202, United States
Unknown Facility
Saint Joseph, Michigan, 49085, United States
Unknown Facility
Chaska, Minnesota, 55318, United States
Unknown Facility
Jefferson City, Missouri, 65109, United States
Unknown Facility
Kansas City, Missouri, 64108, United States
Unknown Facility
Kansas City, Missouri, 64114, United States
Unknown Facility
St Louis, Missouri, 63110, United States
Unknown Facility
St Louis, Missouri, 63117, United States
Unknown Facility
St Louis, Missouri, 63128, United States
Unknown Facility
St Louis, Missouri, 63141, United States
Unknown Facility
Billings, Montana, 59101, United States
Unknown Facility
Omaha, Nebraska, 68131, United States
Unknown Facility
Clifton, New Jersey, 07012, United States
Unknown Facility
Middletown, New Jersey, 07748, United States
Unknown Facility
New Brunswick, New Jersey, 08901, United States
Unknown Facility
Princeton, New Jersey, 08540, United States
Unknown Facility
Brooklyn, New York, 11201, United States
Unknown Facility
East Syracuse, New York, 13057, United States
Unknown Facility
New York, New York, 10011, United States
Unknown Facility
Olean, New York, 14760, United States
Unknown Facility
Rochester, New York, 14609, United States
Unknown Facility
Stony Brook, New York, 11794-8161, United States
Unknown Facility
Durham, North Carolina, 27704, United States
Unknown Facility
Durham, North Carolina, 27705, United States
Unknown Facility
Fayetteville, North Carolina, 28304, United States
Unknown Facility
Morehead City, North Carolina, 28557, United States
Unknown Facility
Morganton, North Carolina, 28655, United States
Unknown Facility
Raleigh, North Carolina, 27609, United States
Unknown Facility
Salisbury, North Carolina, 28144, United States
Unknown Facility
Wilmington, North Carolina, 28401, United States
Unknown Facility
Winston-Salem, North Carolina, 27103, United States
Unknown Facility
Fargo, North Dakota, 58103, United States
Unknown Facility
Grand Forks, North Dakota, 58201, United States
Unknown Facility
Beachwood, Ohio, 44122, United States
Unknown Facility
Canfield, Ohio, 44406, United States
Unknown Facility
Cincinnati, Ohio, 45246, United States
Unknown Facility
Columbus, Ohio, 43213, United States
Unknown Facility
Oklahoma City, Oklahoma, 73112, United States
Unknown Facility
Tulsa, Oklahoma, 74104, United States
Unknown Facility
Medford, Oregon, 97504, United States
Unknown Facility
Portland, Oregon, 97210, United States
Unknown Facility
Bala-Cynwyd, Pennsylvania, 19004, United States
Unknown Facility
Langhorne, Pennsylvania, 19047, United States
Unknown Facility
Philadelphia, Pennsylvania, 19114, United States
Unknown Facility
Philadelphia, Pennsylvania, 19131, United States
Unknown Facility
Wyomissing, Pennsylvania, 19610, United States
Unknown Facility
Charleston, South Carolina, 29425, United States
Unknown Facility
Mt. Pleasant, South Carolina, 29464, United States
Unknown Facility
Spartanburg, South Carolina, 29307, United States
Unknown Facility
Bristol, Tennessee, 37620, United States
Unknown Facility
Memphis, Tennessee, 38103, United States
Unknown Facility
Murfreesboro, Tennessee, 37130, United States
Unknown Facility
Nashville, Tennessee, 37203, United States
Unknown Facility
Sevierville, Tennessee, 37862, United States
Unknown Facility
Carrollton, Texas, 75010, United States
Unknown Facility
Corpus Christi, Texas, 78414, United States
Unknown Facility
Dallas, Texas, 75231, United States
Unknown Facility
Denton, Texas, 76210, United States
Unknown Facility
San Antonio, Texas, 78229, United States
Unknown Facility
Wichita Falls, Texas, 76309, United States
Unknown Facility
Norfolk, Virginia, 23502, United States
Unknown Facility
Norfolk, Virginia, 23507-1912, United States
Unknown Facility
Richmond, Virginia, 23226, United States
Unknown Facility
Richmond, Virginia, 23294, United States
Unknown Facility
Renton, Washington, 98055, United States
Unknown Facility
Seattle, Washington, 98105, United States
Unknown Facility
Seattle, Washington, 98144, United States
Unknown Facility
Spokane, Washington, 99207, United States
Unknown Facility
Tacoma, Washington, 98405, United States
Unknown Facility
Madison, Wisconsin, 53705, United States
Unknown Facility
Milwaukee, Wisconsin, 53209, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Clinical Trials
Hoffmann-La Roche
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2015
First Posted
November 13, 2015
Study Start
June 1, 2004
Primary Completion
April 1, 2006
Study Completion
April 1, 2006
Last Updated
November 2, 2016
Record last verified: 2016-11